SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Feyrter F, Hartmann G. On the carcinoid growth form of the carcinoma mammae, especially the carcinoma solidum (Gelatinosum) mammae. Frankf Z Pathol. 1963; 73: 24-39.
  • 2
    Cubilla AL, Woodruff JM. Primary carcinoid tumor of the breast: a report of 8 patients. Am J Surg Pathol. 1977; 1: 283-292.
  • 3
    Fisher ER, Palekar AS. Solid and mucinous varieties of so-called mammary carcinoid tumors. Am J Clin Pathol. 1979; 72: 909-916.
  • 4
    Azzopardi JG, Muretto P, Goddeeris P, Eusebi V, Lauweryns JM. “Carcinoid” tumours of the breast: the morphological spectrum of argyrophil carcinomas. Histopathology. 1982; 6: 549-569.
  • 5
    Papotti M, Macri L, Finzi G, Capella C, Eusebi V, Bussolati G. Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases. Semin Diagn Pathol. 1989; 6: 174-188.
  • 6
    Rosen PP, Oberman HA. Tumors of the mammary gland. In: Atlas of Tumor Pathology. Washington, DC: AFIP Press; 1993: 236-240.
  • 7
    Maluf HM, Koerner FC. Solid papillary carcinoma of the breast. A form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma. Am J Surg Pathol. 1995; 19: 1237-1244.
  • 8
    Miremadi A, Pinder SE, Lee AH, et al. Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology. 2002; 40: 215-222.
  • 9
    Sapino A, Righi L, Cassoni P, Papotti M, Gugliotta P, Bussolati G. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women. Mod Pathol. 2001; 14: 768-776.
  • 10
    Tavassoli FA, Devilee P. Pathology and genetics. In: Tumors of the Breast and Female Genital Organs. WHO Classification of Tumors Series. Lyon, France: IARC Press; 2003: 32-34.
  • 11
    Zekioglu O, Erhan Y, Ciris M, Bayramoglu H. Neuroendocrine differentiated carcinomas of the breast: a distinct entity. Breast. 2003; 12: 251-257.
  • 12
    Rovera F, Masciocchi P, Coglitore A, et al. Neuroendocrine carcinomas of the breast. Int J Surg. 2008; 6( suppl 1): S113-S115.
  • 13
    Makretsov N, Gilks CB, Coldman AJ, Hayes M, Huntsman D. Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer. Hum Pathol. 2003; 34: 1001-1008.
  • 14
    Lopez-Bonet E, Alonso-Ruano M, Barraza G, Vazquez-Martin A, Bernado L, Menendez JA. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling. Oncol Rep. 2008; 20: 1369-1374.
  • 15
    Bigotti G, Coli A, Butti A, del Vecchio M, Tartaglione R, Massi G. Primary small cell neuroendocrine carcinoma of the breast. J Exp Clin Cancer Res. 2004; 23: 691-696.
  • 16
    Shin SJ, DeLellis RA, Rosen PP. Small cell carcinoma of the breast—additional immunohistochemical studies. Am J Surg Pathol. 2001; 25: 831-832.
  • 17
    Surveillance, Epidemiology, and End Results. Vol 2009. Bethesda, MD: National Cancer Institute; 2009.
  • 18
    Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007; 25: 118-145.
  • 19
    GreeneFL, PageDL, FlemingID, et al, eds. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002: 223-228.
  • 20
    Therneau TM, Grambsch PM. The Cox model. In: TherneauTM, GrambschPM, eds. Modeling Survival Data: Extending the Cox Model. New York, NY: Springer; 2001: 39-78.
  • 21
    van Krimpen C, Elferink A, Broodman CA, Hop WC, Pronk A, Menke M. The prognostic influence of neuroendocrine differentiation in breast cancer: results of a long-term follow-up study. Breast. 2004; 13: 329-333.
  • 22
    Nassar H, Qureshi H, Volkanadsay N, Visscher D. Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas. Am J Surg Pathol. 2006; 30: 501-507.
  • 23
    Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008; 26: 3063-3072.
  • 24
    Weigelt B, Geyer FC, Horlings HM, Kreike B, Halfwerk H, Reis-Filho JS. Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type. Mod Pathol. 2009; 22: 1401-1414.